Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery.

Kardos, Gregory R; Gowda, Raghavendra; Dinavahi, Saketh Sriram; Kimball, Scot; Robertson, Gavin P

Kardos, Gregory R; Gowda, Raghavendra; Dinavahi, Saketh Sriram; Kimball, Scot; Robertson, Gavin P.

Afiliação

Kardos GR; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA, United States.
Gowda R; The Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, Hershey, PA, United States.
Dinavahi SS; The Melanoma Therapeutics Program, The Pennsylvania State University College of Medicine, Hershey, PA, United States.
Kimball S; Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA, United States.
Robertson GP; The Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, Hershey, PA, United States.

Front Oncol ; 10: 834, 2020.

Article em En | MEDLINE | ID: mdl-32637352

Palavras-chave

ALDH18A1; cyclins; eIF2α; protein synthesis; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google